PA83-FhCMB Plant-Derived Recombinant Protective Antigen (rPA) Anthrax Vaccine

30 participants · First posted Sep 12, 2014

Trial to Evaluate the Safety and Immunogenicity of an Anthrax Recombinant Protective Antigen Vaccine

100 participants · First posted Feb 9, 2005

An Open-label, Nonrandomized Study to Evaluate the Safety and Immunogenicity of Raxibacumab With Reinjection

20 participants · First posted Dec 20, 2013

rPA-102

rPA-7909

Recombinant protective antigen vaccines (Pfenex)

ANTIGEN LABORATORIES INC.

United States

TTK HEALTHCARE LIMITED

India

PPG Industries

United States

South Korea Approves World's First Recombinant Anthrax Vaccine BARYTHRAX

NIAB Scientists Develop Next-Generation Leptospirosis Vaccine Strategy

GC Biopharma's BARYTHRAX Becomes World's First Recombinant Anthrax Vaccine to Show Protective Immunity in Phase 2 Trial